# PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy

> **NCT01144897** · PHASE1 · COMPLETED · sponsor: **Daniel Vaena** · enrollment: 5 (actual)

## Conditions studied

- Castrate Resistant Prostate Cancer
- Prostate Cancer

## Interventions

- **RADIATION:** PET Acetate scan
- **DRUG:** Carbon-11 labeled Acetate

## Key facts

- **NCT ID:** NCT01144897
- **Lead sponsor:** Daniel Vaena
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-11
- **Final completion:** 2018-09
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2018-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01144897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01144897, "PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01144897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*